Nureca Share Price
321.10-11.50 (-3.46%)
+27.68% past 1 Year
Nureca Limited is a B2C company engaged in the business of home healthcare and wellness products, which offers quality, durability, functionality, usability and innovative designs. It enables its customers with
Corporate filings & documents
Announcements
Disclosure under Regulation 7(2) of Securities and Exchange Board of India (Prohibition of Insider Trading ) Regulations 2015 ("PIT Regulations ")
5 days agoDisclosure under Regulation 7(2) of Securities and Exchange Board of India (Prohibition of Insider Trading ) Regulations 2015 ("PIT Regulations ")
5 days agoDisclosure under Regulation 7(2) of Securities and Exchange Board of India (Prohibition of Insider Trading )Regulations 2015 (PIT Regulations )
3 weeks agoDisclosure under Regulation 7(2) of Securities and Exchange Board of India (Prohibition of Insider Trading )Regulations 2015 (PIT Regulations )
3 weeks agoAdditional details required for Corporate Announcement under Regulation 30(4) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015.
3 weeks agoAdditional details required for Corporate Announcement under Regulation 30(4) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015.
3 weeks agoPendency of Litigation(s)/disput(s) or the outcome impacting the Company.
4 weeks agoPendency of Litigation(s)/disput(s) or the outcome impacting the Company.
4 weeks agoScrutinizer Report and Voting Results for the 10th Annual General Meeting
1 month agoScrutinizer Report and Voting Results for the 10th Annual General Meeting
1 month agoOutcome and Proceedings of the 10th Annual General Meeting.
1 month agoOutcome and Proceedings of the 10th Annual General Meeting.
1 month agoCopy of Newspaper publication
1 month agoCopy of Newspaper publication
1 month agoUnaudited Financial results for the quarter ended June 30 2026
1 month agoUnaudited Financial results for the quarter ended June 30 2026
1 month agoInvestor Presentation for Q1 & FY27
1 month agoInvestor Presentation for Q1 & FY27
1 month agoUn-audited Financial Results for the quarter ended June 30 2026.
1 month agoUn-audited Financial Results for the quarter ended June 30 2026.
1 month agoCompliance certificate under Reg 74(5) of SEBI(DP) Regulations 2018
1 month agoCompliance certificate under Reg 74(5) of SEBI(DP) Regulations 2018
1 month agoNureca Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 21/07/2026 inter alia to consider and approve Nureca Limited has informed the exchange regarding Board Meeting date for the declaration of Unaudited Financial results for the quarter ended June 30 2026 and Other business matters.
1 month agoNureca Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 21/07/2026 inter alia to consider and approve Nureca Limited has informed the exchange regarding Board Meeting date for the declaration of Unaudited Financial results for the quarter ended June 30 2026 and Other business matters.
1 month agoThe Exchange has received the disclosure under Regulation 10(7) in respect of acquisition under Regulation 10(1)(a)(ii)of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Saurabh Goyal
1 month agoThe Exchange has received the disclosure under Regulation 10(7) in respect of acquisition under Regulation 10(1)(a)(ii)of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Saurabh Goyal
1 month agoThe Exchange has received the disclosure under Regulation 10(6) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Saurabh Goyal
1 month agoThe Exchange has received the disclosure under Regulation 10(6) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Saurabh Goyal
1 month agoResubmission of a More Legible Copy of the Notice of 10th Annual General Meeting (AGM) and Annual Report 2025-26 submitted on 03 July 2026.
1 month agoResubmission of a More Legible Copy of the Notice of 10th Annual General Meeting (AGM) and Annual Report 2025-26 submitted on 03 July 2026.
1 month agoThe Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Saurabh Goyal
1 month agoThe Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Saurabh Goyal
1 month agoThe Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Payal Goyal
1 month agoThe Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Payal Goyal
1 month agoThe Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Aryan Goyal
1 month agoThe Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Aryan Goyal
1 month agoNureca Limited has informed the exchange regarding newspaper publication.
2 months agoNureca Limited has informed the exchange regarding newspaper publication.
2 months agoNureca Limited has informed the exchange regarding Notice of 10th AGM of the company along with its Annual Report for the FY25-26.
2 months agoNureca Limited has informed the exchange regarding Notice of 10th AGM of the company along with its Annual Report for the FY25-26.
2 months agoNureca Limited has informed the exchange regarding Annual Report for the FY 25-26.
2 months agoNureca Limited has informed the exchange regarding Annual Report for the FY 25-26.
2 months agoNureca Limited has informed the exchange regarding disclosure under Regulation 7(2) of Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations 2015 ("PIT Regulations")
2 months agoNureca Limited has informed the exchange regarding disclosure under Regulation 7(2) of Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations 2015 ("PIT Regulations")
2 months agoNureca Limited has informed the exchange regarding disclosure under Regulation 7(2) of Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations 2015 ("PIT Regulations")
2 months agoNureca Limited has informed the exchange regarding disclosure under Regulation 7(2) of Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations 2015 ("PIT Regulations")
2 months agoNureca Limited has informed the exchange regarding disclosure under Regulation 7(2) of Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations 2015 ("PIT Regulations")
2 months agoNureca Limited has informed the exchange regarding disclosure under Regulation 7(2) of Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations 2015 ("PIT Regulations")
2 months agoNureca Limited has informed the Exchange regarding Newspaper Publication.
2 months agoNureca Limited has informed the Exchange regarding Newspaper Publication.
2 months agoAnnual reports
Concalls & investor presentations
Jul 2026
ConcallPresentation
May 2026
ConcallPresentation
Jan 2026
ConcallPresentation
Jul 2025
ConcallPresentation
May 2025
ConcallPresentation
Jan 2025
ConcallPresentation
Oct 2024
ConcallPresentation
Aug 2024
ConcallPresentation
May 2024
ConcallPresentation
Feb 2024
ConcallPresentation
Nov 2023
ConcallPresentation
Aug 2023
ConcallPresentation
Aug 2022
ConcallPresentation
Jul 2021
ConcallPresentation
Corporate Actions
Date
Type
Details
2022-02-24
Dividend
3.0
2021-09-21
Dividend
2.0
Company details
Registered office
B-205, Bldg - 42, B Wing Dhanashree Heights, Azad Nagar Sangam C H S Andheri West Mumbai Maharashtra PIN: 400053 Tel No: 0172-5292900 Fax No: NULL Email: [email protected] Internet: www.nureca.com
Registrars
205-208 , Anarkali Complex,Jhandewala Extension,New Delhi 205-208 , Anarkali Complex Jhandewala Extension NULL PIN: Tel No: 011-23610220-24 Fax No: 011-23552001 Email: NULL
Management
Saurabh Goyal, Chairman & Managing Director
Saurabh Goyal, Chairman & Managing Director
Rajinder Sharma, Whole Time Director
Smita Goyal, Whole Time Director
Vijay Kumar Sharma, Non Executive Independent Director
Charu Singh, Non Executive Independent Director
Ruchita Agarwal, Non Executive Independent Director
Rupinder Tewari, Non Executive Independent Director
Kuldip Kumar Bhasin, Non Executive Independent Director
Nishu Kansal, Company Secretary & Compliance Officer
Details
BSE 543264
NSE NURECA
ISIN INE0DSF01015